Vec

# Vec ## Overview - **Classification**: Non-depolarizing neuromuscular blocker (NMBA) - **Mechanism**: Competitively binds to nicotinic acetylcholine receptors at the neuromuscular junction, preventing acetylcholine from binding and causing muscle paralysis. ## Primary Indications 1. **Skeletal Muscle Relaxation**: Facilitates tracheal intubation. 2. **Skeletal Muscle Relaxation**: Provides muscle relaxation during surgery or mechanical ventilation. ## Adult Dosing ### Standard Dosing **Tracheal Intubation** - **Dose**: **0.08 to 0.1 mg/kg** IV bolus - **Frequency**: Single dose for intubation - **Route**: Intravenous (IV) - **Duration**: Onset ~2.5-3 min, clinical duration ~25-40 min **Maintenance of Neuromuscular Blockade** - **Dose (Intermittent)**: **0.01 to 0.015 mg/kg** IV bolus - **Frequency**: Administer when twitch response returns to 25% of control - **Route**: Intravenous (IV) - **Dose (Continuous Infusion)**: **0.8 to 1.2 mcg/kg/minute** (0.0008-0.0012 mg/kg/min) - **Maximum Infusion**: Up to 1.7 mcg/kg/minute in some cases, titrated to effect. ### Dose Adjustments - **Renal Impairment**: Prolonged duration of action; consider reduced initial dose or lower infusion rate. - **Hepatic Impairment**: Prolonged duration of action; closely monitor neuromuscular blockade. - **Elderly Patients**: May have prolonged duration; consider lower initial dose and slower infusion. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: Initial dose of **0.08 to 0.1 mg/kg** IV bolus - **Frequency**: Subsequent doses **0.01 to 0.015 mg/kg** IV, as needed - **Maximum**: Titrate to effect with close monitoring. - **Special Notes**: May have a longer duration of action; monitor closely. ### Infants (1-12 months) - **Dose**: Initial dose of **0.08 to 0.1 mg/kg** IV bolus - **Frequency**: Subsequent doses **0.01 to 0.015 mg/kg** IV, as needed - **Maximum**: Titrate to effect. ### Children (1-12 years) - **Dose**: Initial dose of **0.08 to 0.1 mg/kg** IV bolus - **Frequency**: Subsequent doses **0.01 to 0.015 mg/kg** IV, as needed - **Maximum**: Follow adult per kg dosing guidelines. ### Adolescents (13-18 years) - **Dose**: Adult dosing guidelines apply: **0.08 to 0.1 mg/kg** IV bolus. - **Maximum**: Adult maximums per kg. ## Safety Information ### Contraindications - **Absolute**: Known hypersensitivity to vecuronium or bromides. - **Absolute**: Lack of ventilatory support and ability to manage airway. - **Relative**: Patients with myasthenia gravis or other neuromuscular diseases (increased sensitivity). ### Common Adverse Effects - **Common (1-10%)**: Residual muscle weakness, prolonged neuromuscular blockade. - **Serious but Rare**: Anaphylaxis, bronchospasm, cardiovascular collapse. ### Key Drug Interactions - **Inhalation Anesthetics (e.g., Isoflurane, Sevoflurane)**: Potentiate blockade; requires reduced vecuronium dose. - **Aminoglycoside Antibiotics (e.g., Gentamicin)**: Enhance and prolong neuromuscular blockade. - **Magnesium Sulfate**: Enhances and prolongs neuromuscular blockade. - **Corticosteroids (chronic use)**: May lead to steroid-induced myopathy when co-administered. ## Monitoring & Follow-up - **Before Treatment**: Assess baseline neuromuscular function (if possible), renal/hepatic function. - **During Treatment**: **Neuromuscular monitoring (e.g., Train-of-Four)** is essential. - **During Treatment**: Monitor heart rate, blood pressure, oxygen saturation, and end-tidal CO2. - **Clinical Signs**: Assess for adequate paralysis vs. signs of recovery or residual block. ## Clinical Pearls - 💡 **Tip 1**: Always ensure a patent airway and ventilatory support are immediately available. - 💡 **Tip 2**: Use a peripheral nerve stimulator (e.g., Train-of-Four) to titrate dose and assess recovery. - 💡 **Tip 3**: Have reversal agents (e.g., Neostigmine, Sugammadex) readily available. - 💡 **Tip 4**: Consider lower doses in patients with renal/hepatic impairment, and the elderly. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.